"Body, Mind, and Self: ACT With Psychoeducation for Female Students Facing Eating Challenges"

May 1, 2026 updated by: Shereen
Background: Disturbed eating attitudes are complex mental health conditions that often involve distorted body-image perception, low self-esteem, and heightened anxiety, and affect physical, emotional, and social well-being. Globally, they are considered major mental health problems, particularly among adolescents and young adults. So, this study aimed to evaluate the effectiveness of acceptance and commitment therapy integrated with psychoeducation on self-esteem, body-image perception, and anxiety among female university students with disturbed eating attitudes. Subjects and method: A quasi-experimental research (pre/post) two groups (study/control) design was utilized from JAN 2026 to APRIL 2026. Setting: The study was conducted at the four faculties, Menoufia University, Menoufia Governorate, Egypt. Subjects: A purposive sample of 120 students was selected from the previously mentioned setting. Tools of data collection: Five valid tools were used in data collection, tool 1: A structured interview questionnaire to assess socio-demographic characteristics of the studied subjects, tool 2: Rosenberg Self-Esteem Scale (RSES) a widely used measure of self-esteem, tool 3: Body Appreciation Scale (BAS) to assess positive body image by measuring acceptance, favorable opinions, respect, and protective behaviors toward one's body, tool 4: Beck Anxiety Inventory (BAI) to measure the severity of anxiety symptoms in adults and adolescents, tool 5: The Eating Attitudes Test (EAT-26) widely used screening tools for identifying symptoms of anorexia nervosa and other eating disorders in both clinical and non-clinical populations. Data was analyzed at two points: pre- and post-intervention. Results: Showed no statistically significant differences between the two groups in the levels of self-esteem, body image perception, anxiety, and disturbed eating attitudes pre-intervention. But post intervention, the study group exhibited significant improvement in self-esteem, body image perception, anxiety, and disturbed eating attitudes. Conclusion: The acceptance and commitment therapy integrated with psychoeducation effectively enhances self-esteem, body-image perception, reduces anxiety, and improves disturbed eating attitudes among female university students with disturbed eating attitudes (study group). Recommendations: Offer simulation-based training for handling complex eating disorder cases, establish multidisciplinary teams (Nurses, psychologists, dietitians) for holistic care plans, Advocate for community awareness programs to reduce stigma and promote early intervention, and develop digital well-being initiatives, including social media detox strategies, as part of adolescence education.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
120

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Shibīn al Kawm, Egypt
        • Faculty of nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 and 25 years of age which is the range fit for college students,
  • had experience with disturbed eating attitudes,
  • able to communicate and participate.

Exclusion Criteria:

  • had severe psychiatric comorbidity (psychosis, substance abuse) or
  • cognitive impairment.
  • not willing to participate in the study,
  • not willing to provide written consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: study groups
will receive the sessions
Behavioral: receive acceptance and commitment therapy integrated with psychoeducation intervention sessions
-Study group students were divided into 6 subgroups of 10 students each. Each subgroup was provided with eight acceptance and commitment therapy integrated with psychoeducation intervention sessions (one session per week on each Sunday for eight consecutive weeks), each lasting approximately 45-60 minutes. The sessions were conducted by one researcher for each group, with six groups being accommodated per day. The sessions given for each researcher are two groups per day which take place from 10 am to 10:45 or 11 am and from 11:15 am to 12:00 or 12:15 pm. The program was implemented over a period of 8 weeks, completing the sessions within two months.
Active Comparator: control group
will not receive the sessions only regular care
Other: regular care
control group (N = 60): did not receive the acceptance and commitment therapy integrated with psychoeducation sessions during the study period.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Rosenberg Self-Esteem Scale Score range: SCORE RANGE FROM 10 to 40
Time Frame: 8 weeks
HIGHER score means higher self-esteem
8 weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
The Body Appreciation Scale, scores range 10-50
Time Frame: 8 weeks
high score mean higher or good body-image perception
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Shereen

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Menoufia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 15, 2026

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 19, 2026

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
April 19, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 21, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 1, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 7, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 7, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 1, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • ERCNMA 1000/4/1/192/26

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings